A Molecular Therapeutics cancer drug candidate, one of the surviving programs of a recent corporate shakeup that slashed the company’s workforce in half, is now on pause. The FDA is asking for more ...

> Molecular Templates a biopharmaceutical company developing what it calls a new class of small biologic therapies called Engineered Toxin Bodies has entered into a research collaboration with Alnylam ...

GEORGETOWN, Texas--(BUSINESS WIRE)--Molecular Templates, Inc., a biopharmaceutical company focused on the discovery and development of a new class of small biologic therapies called Engineered Toxin ...

Engineered toxin bodies reportedly possess active intracellular properties that may be helpful in overcoming delivery hurdles. Molecular Templates entered into a research collaboration with Alnylam ...

The fast and targeted delivery of drugs could soon be made easier. Microcontainers for medical substances can be produced in different sizes using calcium carbonate microspheres as templates, new ...

Thanks to our understanding of molecular biology, we have made tremendous progress in medicine, with scientists shedding light on the molecular mechanisms of several diseases. However, despite knowing ...